1. Home
  2. PTCT vs STNE Comparison

PTCT vs STNE Comparison

Compare PTCT & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • STNE
  • Stock Information
  • Founded
  • PTCT 1998
  • STNE 2012
  • Country
  • PTCT United States
  • STNE Cayman Islands
  • Employees
  • PTCT N/A
  • STNE N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • STNE EDP Services
  • Sector
  • PTCT Health Care
  • STNE Technology
  • Exchange
  • PTCT Nasdaq
  • STNE Nasdaq
  • Market Cap
  • PTCT 3.7B
  • STNE 3.6B
  • IPO Year
  • PTCT 2013
  • STNE 2018
  • Fundamental
  • Price
  • PTCT $50.34
  • STNE $14.52
  • Analyst Decision
  • PTCT Buy
  • STNE Buy
  • Analyst Count
  • PTCT 14
  • STNE 8
  • Target Price
  • PTCT $63.57
  • STNE $15.63
  • AVG Volume (30 Days)
  • PTCT 939.9K
  • STNE 6.3M
  • Earning Date
  • PTCT 08-07-2025
  • STNE 08-13-2025
  • Dividend Yield
  • PTCT N/A
  • STNE N/A
  • EPS Growth
  • PTCT N/A
  • STNE N/A
  • EPS
  • PTCT 7.51
  • STNE N/A
  • Revenue
  • PTCT $1,772,758,000.00
  • STNE $2,314,839,446.00
  • Revenue This Year
  • PTCT $121.50
  • STNE $24.50
  • Revenue Next Year
  • PTCT N/A
  • STNE $7.81
  • P/E Ratio
  • PTCT $6.72
  • STNE N/A
  • Revenue Growth
  • PTCT 91.12
  • STNE 12.87
  • 52 Week Low
  • PTCT $28.72
  • STNE $7.72
  • 52 Week High
  • PTCT $58.38
  • STNE $15.27
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 54.78
  • STNE 57.60
  • Support Level
  • PTCT $49.47
  • STNE $13.52
  • Resistance Level
  • PTCT $52.45
  • STNE $15.27
  • Average True Range (ATR)
  • PTCT 1.54
  • STNE 0.62
  • MACD
  • PTCT -0.09
  • STNE 0.07
  • Stochastic Oscillator
  • PTCT 49.17
  • STNE 66.22

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

Share on Social Networks: